Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction
Condition:   Heart Failure, Systolic Intervention:   Drug: Sacubitril/valsartan Sponsor:   National Institute of Cardiovascular Diseases, Karachi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials

Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
Condition:   Hypertrophic Cardiomyopathy Interventions:   Drug: Sacubitril/Valsartan;   Behavioral: Lifestyle Sponsors:   Newcastle-upon-Tyne Hospitals NHS Trust;   University Hospital Regensburg;   Assistance Publique - Hôpitaux de Paris;   Azienda Ospedaliero-Universitaria Careggi;   Institute for Cardiovascular Diseases of Vojvodina Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2022 Category: Research Source Type: clinical trials